With increase in incidence of chronic diseases that can lead to organ
failure, the global transplant diagnostics market is expected to only
grow further in future. Transplant diagnostics in simpler terms is a
test done to ascertain the compatibility between the recipient and
donor of organ before or after transplant.
Based on technology, the global transplant diagnostics market can be
segmented into molecular assays and non-molecular assays. The
molecular assay technologies segment can be further segmented into
sequencing based and PCR based. In terms of products and services,
market can be classified into reagents & consumables,
instruments, and software and services. On the basis of application,
the global transplant diagnostics market can be categorized into
diagnostic applications and research applications. The diagnostic
applications segment can be further segmented into blood profiling,
histocompatibility testing, infectious disease diagnostics, and
research applications.
The report offers an inclusive outline of various factors
contributing to the expansion of the global transplant diagnostics
market. It also delivers insights into challenges that the market
could face over the forecast period. The dominant trends in overall
market operations are also examined in the report in detail.
The rise of the global transplant diagnostics market can be
accredited to various factors such as technological advancements in
the field of genetics, coupled with increasing responsiveness among
healthcare professionals about the benefits presented by molecular
assay techniques and increasing number of tissue, solid organ, and
stem cell transplantation procedures. However, expensive transplant
diagnostic products, inadequate medical reimbursements for organ
donation and transplant procedures, and unwillingness for organ
donation across developing and comparatively lesser developing
economies are acting as obstacle for the growth of the market.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20225
Based on products and services, the instruments segment is projected
to hold a large market share. Factors such as increasing awareness
regarding benefits offered by genome-based donor-recipient profiling,
increasing commercialization of innovative transplant diagnostic
instruments, ongoing technological advancements in the field of
transplant diagnostics, and increasing awareness are driving the
growth of this market.
The diagnostic applications segment is the key contributor to the
market share, and is expected to lead the market in the forecast
period. Advanced technology and increasing investments are a few
factors driving the market growth. The molecular assay technologies
segment shows a promising growth, expected to register a high CAGR
over the forecast period.
On the basis of geography, the global market of transplant
diagnostics can be divided into Asia Pacific, Europe North America,
and Rest of the World. Due to a large pool of geriatric population
Asia Pacific is a potential market for transplant diagnostics. In
addition, growing awareness related to transplant diagnostic
procedures, escalating incidence of chronic and infectious diseases,
and continuously rising healthcare expenditure are a few of the
factors that can be attributed to the growth of this region. To
supplement growth opportunities, leading players are venturing into
this promising market.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=20225<ype=S
The growing responsiveness for organ donation in European countries
has resulted in increased number of living organ donors, thereby
driving the market growth in Europe.
The report profiles some of the prominent competitors operating in
the market. It also provides insights into the challenges and
opportunities that the companies are projected to witness in the
coming years. Some of the players in the global transplant
diagnostics market are Thermo Fisher Scientific Inc., Illumina, Inc.,
F. Hoffman-La Roche Ltd., QIAGEN N.V., Immucor, Inc., bioMérieux
S.A., Bio-Rad Laboratories, Inc., Becton Dickinson and Company,
CareDx, and GenDx.
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment